{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:25:12Z","timestamp":1791829512367,"version":"4.3.4"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012617","name":"Moorfields Eye Hospital NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012617","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017645","name":"Moorfields Eye Charity","doi-asserted-by":"publisher","award":["GR001061"],"award-info":[{"award-number":["GR001061"]}],"id":[{"id":"10.13039\/501100017645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000282","name":"Sir Jules Thorn Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000367","name":"British Council for Prevention of Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017151","name":"Queen Elizabeth Diamond Jubilee Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["207472\/Z\/17\/Z"],"award-info":[{"award-number":["207472\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014445","name":"Fred Hollows Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014445","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.eclinm.2022.101354","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T01:02:02Z","timestamp":1647910922000},"page":"101354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"special_numbering":"C","title":["The economics of vision impairment and its leading causes: A systematic review"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-7021","authenticated-orcid":false,"given":"Ana Patricia","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Ramke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marty","family":"Jovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyala","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Faal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bastawrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasanee","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Resnikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng T.","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Frick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0001","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.eclinm.2022.101354_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30488-5","article-title":"The Lancet Global Health Commission on global eye health: vision beyond 2020","author":"Burton","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0003","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1371\/journal.pmed.0050244","article-title":"A case-control study to assess the relationship between poverty and visual impairment from cataract in Kenya, the Philippines, and Bangladesh","volume":"5","author":"Kuper","year":"2008","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101354_bib0004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09286580601139212","article-title":"Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions","volume":"14","author":"Langelaan","year":"2007","journal-title":"Ophthalmic Epidemiol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000316688","article-title":"Impact of low vision on employment","volume":"224","author":"Mojon-Azzi","year":"2010","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.eclinm.2022.101354_bib0006","first-page":"35","article-title":"Global economic productivity losses from vision impairment and blindness","author":"Marques","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ophtha.2007.04.016","article-title":"Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999","volume":"115","author":"Coleman","year":"2008","journal-title":"Ophthalmology"},{"issue":"1_suppl","key":"10.1016\/j.eclinm.2022.101354_bib0008","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/0145482X0610001S07","article-title":"double jeopardy: the effects of comorbid conditions among older people with vision loss","volume":"100","author":"Crews","year":"2006","journal-title":"J Vis Impair Blind"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0009","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ajo.2012.10.003","article-title":"Diffusion of technologies for the care of older adults with exudative age-related macular degeneration","volume":"155","author":"Stein","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.eclinm.2022.101354_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009006","article-title":"Diffusion of anti-VEGF injections in the Portuguese National Health System","volume":"5","author":"Marques","year":"2015","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.eclinm.2022.101354_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003471","article-title":"The economic burden of visual impairment and blindness: a systematic review","volume":"3","author":"Koberlein","year":"2013","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0012","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101354_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036689","article-title":"Estimating the global cost of vision impairment and its major causes: protocol for a systematic review","volume":"10","author":"Marques","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2022.101354_bib0014","series-title":"International Classification of Diseases 11th Revision (ICD11)","year":"2021"},{"issue":"7052","key":"10.1016\/j.eclinm.2022.101354_bib0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","article-title":"Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ economic evaluation working party","volume":"313","author":"Drummond","year":"1996","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0016","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1524-4733.2008.00327.x","article-title":"Methodological considerations in cost of prostate cancer studies: a systematic review","volume":"11","author":"Molinier","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.eclinm.2022.101354_bib0017","series-title":"World Development Indicators: GDP Deflator (base year varies by country)","year":"2020"},{"key":"10.1016\/j.eclinm.2022.101354_bib0018","series-title":"World Development Indicators: PPP Conversion factor, GDP (LCU Per International $)","year":"2020"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0019","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jval.2021.01.002","article-title":"Critical appraisal of systematic reviews with costs and cost-effectiveness outcomes: an ISPOR good practices task force report","volume":"24","author":"Mandrik","year":"2021","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101354_bib0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies: a guide to critical evaluation","volume":"29","author":"Larg","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.eclinm.2022.101354_bib0021","series-title":"Methods For the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101354_bib0022","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bjo.2005.080986","article-title":"The economic impact and cost of visual impairment in Australia","volume":"90","author":"Taylor","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.eclinm.2022.101354_bib0023","unstructured":"Economics A. Clear focus: the economic impact of vision loss in Australia in 2009: Melbourne, Australia; 2010."},{"key":"10.1016\/j.eclinm.2022.101354_bib0024","unstructured":"Economics A. Tunnel vision: the economic impact of primary open angle glaucoma: Melbourne, Australia; 2011."},{"key":"10.1016\/j.eclinm.2022.101354_bib0025","series-title":"The Economic Impact of Diabetic Eye Disease: A Dynamic Economic Model","author":"Economics","year":"2008"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0026","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archophthalmol.2010.86","article-title":"Economic cost of visual impairment in Japan","volume":"128","author":"Roberts","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0027","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jcjo.2011.07.001","article-title":"The cost of vision loss in Canada. 1. Methodology","volume":"46","author":"Gordon","year":"2011","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0028","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jcjo.2011.06.006","article-title":"The cost of vision loss in Canada. 2. Results","volume":"46","author":"Cruess","year":"2011","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12913-018-2836-0","article-title":"The economic impact of sight loss and blindness in the UK adult population","volume":"18","author":"Pezzullo","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0030","first-page":"338","article-title":"Cost-effectiveness analysis of cataract surgery: a global and regional analysis","volume":"82","author":"Baltussen","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0031","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09286580590932761","article-title":"Cost-effectiveness of trachoma control in seven world regions","volume":"12","author":"Baltussen","year":"2005","journal-title":"Ophthalmic Epidemiol"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0032","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/17441692.2011.634815","article-title":"An estimation of the worldwide economic and health burden of visual impairment","volume":"7","author":"Gordois","year":"2012","journal-title":"Glob Public Health"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0033","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9394(02)02110-4","article-title":"The magnitude and cost of global blindness: an increasing problem that can be alleviated","volume":"135","author":"Frick","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101354_bib0034","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ophtha.2018.10.029","article-title":"Potential lost productivity resulting from the global burden of myopia: systematic review, meta-analysis, and modeling","volume":"126","author":"Naidoo","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1076\/opep.10.2.121.13899","article-title":"Estimating the burden and economic impact of trachomatous visual loss","volume":"10","author":"Frick","year":"2003","journal-title":"Ophthalmic Epidemiol"},{"issue":"5 Suppl","key":"10.1016\/j.eclinm.2022.101354_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2003.69.5_suppl_1.0690001","article-title":"Global burden of trachoma and economics of the disease","volume":"69","author":"Frick","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101354_bib0037","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.ophtha.2015.04.014","article-title":"The global burden of potential productivity loss from uncorrected presbyopia","volume":"122","author":"Frick","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0038","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/09286586.2015.1066394","article-title":"A simple method for estimating the economic cost of productivity loss due to blindness and moderate to severe visual impairment","volume":"22","author":"Eckert","year":"2015","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.eclinm.2022.101354_bib0039","first-page":"1","article-title":"Thirty year projected magnitude (to 2050) of near and distance vision impairment and the economic impact if existing solutions are implemented globally","author":"Bastawrous","year":"2019","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/09286586.2017.1281426","article-title":"The economic impact of blindness in Europe","volume":"24","author":"Chakravarthy","year":"2017","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005289","article-title":"The socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases","volume":"11","author":"Redekop","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198631","article-title":"The use of informal care by people with vision impairment","volume":"13","author":"Marques","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101354_bib0043","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archophthalmol.2009.242","article-title":"The cost of care for people with impaired vision in Australia","volume":"127","author":"Keeffe","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.eclinm.2022.101354_bib0044","first-page":"1","article-title":"Productivity losses and their explanatory factors amongst people with impaired vision","author":"Marques","year":"2019","journal-title":"Ophthalmic Epidemiol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0045","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.2003.00972.x","article-title":"The impact of diabetes-related complications on healthcare costs: results from the United Kingdom prospective diabetes Study (UKPDS Study No. 65)","volume":"20","author":"Clarke","year":"2003","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0046","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/dme.12647","article-title":"The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)","volume":"32","author":"Alva","year":"2015","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101354_bib0047","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.87.10.1201","article-title":"What is the cost of blindness?","volume":"87","author":"Meads","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0048","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/1010539515588944","article-title":"Clinical and economic burden of visual impairment in an aging society of South Korea","volume":"27","author":"Park","year":"2015","journal-title":"Asia Pac J Public Health"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0049","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ophtha.2007.02.007","article-title":"Direct costs of blindness experienced by patients enrolled in managed care","volume":"115","author":"Frick","year":"2008","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/09286586.2013.839800","article-title":"Costs of eye care services: prospective study from a faith-based hospital in Zambia","volume":"22","author":"Griffiths","year":"2015","journal-title":"Ophthalmic Epidemiol"},{"issue":"101088677","key":"10.1016\/j.eclinm.2022.101354_bib0051","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12913-015-0831-2","article-title":"Direct non-medical costs double the total direct costs to patients undergoing cataract surgery in Zamfara state, Northern Nigeria: a case series","volume":"15","author":"Ibrahim","year":"2015","journal-title":"BMC Health Serv Res"},{"issue":"9199","key":"10.1016\/j.eclinm.2022.101354_bib0052","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(99)07430-9","article-title":"Cost-effectiveness of public-funded options for cataract surgery in Mysore, India","volume":"355","author":"Singh","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0053","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/09286580490888762","article-title":"Economic cost of cataract surgery procedures in an established eye care centre in Southern India","volume":"11","author":"Muralikrishnan","year":"2004","journal-title":"Ophthalmic Epidemiol"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101354_bib0054","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archophthalmol.2010.136","article-title":"Simultaneous vs sequential bilateral cataract surgery for infants with congenital cataracts: visual outcomes, adverse events, and economic costs","volume":"128","author":"Dave","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"39\u201340 Pt 1","key":"10.1016\/j.eclinm.2022.101354_bib0055","first-page":"1924","article-title":"[Cost of managing cataracts. Evaluation of traditional hospitalization and ambulatory surgery]","volume":"30","author":"Nghiem-Buffet","year":"2001","journal-title":"Presse Med"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0056","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10384-011-0041-3","article-title":"Cost-effectiveness of cataract surgery in Japan","volume":"55","year":"2011","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0057","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2017-000123","article-title":"Ready-made and custom-made eyeglasses in India: a cost-effectiveness analysis of a randomised controlled trial","volume":"3","author":"Angell","year":"2018","journal-title":"BMJ open Ophthalmol"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0058","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/09286580902999421","article-title":"Economics and attitudes regarding spectacles in daily life: a European perspective","volume":"16","author":"Lafuma","year":"2009","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.eclinm.2022.101354_bib0059","first-page":"1","article-title":"Five-year cost-effectiveness of intravitreous ranibizumab therapy vs panretinal photocoagulation for treating proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial","author":"Hutton","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"101321512","key":"10.1016\/j.eclinm.2022.101354_bib0060","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2147\/OPTH.S37145","article-title":"Economic burden of glaucoma in Rivers State, Nigeria","volume":"6","author":"Adio","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0061","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1185\/03007990802111068","article-title":"Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries","volume":"24","author":"Thygesen","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0062","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/jamaophthalmol.2015.44","article-title":"Comparative cost-effectiveness of the baerveldt implant, trabeculectomy with mitomycin, and medical treatment","volume":"133","author":"Kaplan","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.eclinm.2022.101354_bib0063","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005094","article-title":"Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial","volume":"4","author":"Dakin","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0064","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12886-017-0617-x","article-title":"Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland","volume":"17","author":"Reich","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12886-018-0731-4","article-title":"Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context","volume":"18","author":"Schmid","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0066","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1186\/s12913-019-4666-0","article-title":"Incremental economic burden associated with exudative age-related macular degeneration: a population-based study","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"10.1016\/j.eclinm.2022.101354_bib0067","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ophtha.2010.02.032","article-title":"A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact","volume":"117","author":"Gupta","year":"2010","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0068","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/ICO.0b013e31802b36dc","article-title":"Economic analysis of corneal ulcers in South India","volume":"26","author":"Prajna","year":"2007","journal-title":"Cornea"},{"issue":"2\u20133","key":"10.1016\/j.eclinm.2022.101354_bib0069","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1076\/opep.8.2.191.4163","article-title":"Epidemiological, demographic, and economic analyses: measurement of the value of trichiasis surgery in The Gambia","volume":"8","author":"Frick","year":"2001","journal-title":"Ophthalmic Epidemiol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00061198-200312000-00002","article-title":"Cost of glaucoma in Canada: analyses based on visual field and physician's assessment","volume":"12","author":"Iskedjian","year":"2003","journal-title":"J Glaucoma"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0071","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/jamaophthalmol.2015.5479","article-title":"Self-reported function, health resource use, and total health care costs among medicare beneficiaries with glaucoma","volume":"134","author":"Prager","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0072","first-page":"145","article-title":"Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand","volume":"7","author":"Dilokthornsakul","year":"2014","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0073","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/IAE.0000000000000717","article-title":"Societal costs associated with neovascular Age-related Macular Degeneration in the United States","volume":"36","author":"Brown","year":"2016","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0074","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/bjo.2007.118687","article-title":"Falls and health status in elderly women following first eye cataract surgery: an economic evaluation conducted alongside a randomised controlled trial","volume":"91","author":"Sach","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101354_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135050","article-title":"Comparison of outcomes and costs of ranibizumab and aflibercept treatment in real-life","volume":"10","author":"Schmid","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.eclinm.2022.101354_bib0076","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1185\/03007990802214300","article-title":"Burden of illness of bilateral neovascular age-related macular degeneration in Spain","volume":"24","author":"Ruiz-Moreno","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0077","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00019053-200826010-00006","article-title":"Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study","volume":"26","author":"Cruess","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0078","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ajo.2011.05.008","article-title":"Medicare costs for neovascular age-related macular degeneration, 1994-2007","volume":"152","author":"Day","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0079","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ajo.2012.04.017","article-title":"Patterns and costs associated with progression of age-related macular degeneration","volume":"154","author":"Schmier","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101354_bib0080","first-page":"149","article-title":"Cost data assessment in multinational economic evaluations: some theory and review of published studies","volume":"2","author":"Halliday","year":"2003","journal-title":"Appl Health Econ Health Policy"},{"issue":"7 Suppl","key":"10.1016\/j.eclinm.2022.101354_bib0081","first-page":"5","article-title":"Common methodological flaws in economic evaluations","volume":"43","author":"Drummond","year":"2005","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0082","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00019053-200725060-00003","article-title":"A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers?","volume":"25","author":"Teerawattananon","year":"2007","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0083","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated health economic evaluation reporting standards (CHEERS)\u2013explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0084","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00019053-199711010-00009","article-title":"Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature","volume":"11","author":"Agro","year":"1997","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S0266462316000660","article-title":"Systematic reviews of economic evaluations: how extensive are their searches?","volume":"33","author":"Wood","year":"2017","journal-title":"Int J Technol Assess Health Care"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0086","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jclinepi.2014.11.025","article-title":"Librarian co-authors correlated with higher quality reported search strategies in general internal medicine systematic reviews","volume":"68","author":"Rethlefsen","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2022.101354_bib0087","unstructured":"Vassal A.S.S, Kahn J., Gomez Guillen G., et\u00a0al. Reference case for estimating the costs of global health services and interventions. In: Consortium GHC, editor.; 2017."},{"key":"10.1016\/j.eclinm.2022.101354_bib0088","series-title":"Methods for Economic Evaluation Project (MEEP) Final Report","year":"2014"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101354_bib0089","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jval.2016.04.015","article-title":"The international decision support initiative reference case for economic evaluation: an aid to thought","volume":"19","author":"Wilkinson","year":"2016","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0090","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1167\/iovs.09-4469","article-title":"The cost of visual impairment: purposes, perspectives, and guidance","volume":"51","author":"Frick","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0091","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00019053-199814020-00001","article-title":"Cost-of-illness studies. Useful for health policy?","volume":"14","author":"Koopmanschap","year":"1998","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101354_bib0092","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ophtha.2014.03.017","article-title":"Health burden associated with visual impairment in Singapore: the Singapore epidemiology of eye disease study","volume":"121","author":"Wang","year":"2014","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0093","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1167\/iovs.13-12795","article-title":"The economic cost of myopia in adults aged over 40 years in Singapore","volume":"54","author":"Zheng","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0094","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/09286586.2016.1193617","article-title":"Burden of wet age-related macular degeneration and its economic implications in Singapore in the year 2030","volume":"23","author":"Saxena","year":"2016","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.eclinm.2022.101354_bib0095","article-title":"Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study","volume":"101134867","author":"Chuvarayan","year":"2019","journal-title":"Eur J Health Econ"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0096","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/00019053-200624020-00007","article-title":"Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK","volume":"24","author":"Lafuma","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0097","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archopht.124.12.1754","article-title":"The economic burden of major adult visual disorders in the United States","volume":"124","author":"Rein","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0098","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archopht.125.4.544","article-title":"Economic impact of visual impairment and blindness in the United States","volume":"125","author":"Frick","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101354_bib0099","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.ophtha.2013.01.068","article-title":"The economic burden of vision loss and eye disorders among the United States population younger than 40 years","volume":"120","author":"Wittenborn","year":"2013","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0100","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ophtha.2006.06.033","article-title":"Costs of refractive correction of distance vision impairment in the United States, 1999-2002","volume":"113","author":"Vitale","year":"2006","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0101","first-page":"1013","article-title":"Refractive surgery: the most cost-saving technique in refractive errors correction","volume":"11","author":"Mohammadi","year":"2018","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0102","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4103\/0301-4738.100527","article-title":"The economic burden of blindness in Pakistan: a socio-economic and policy imperative for poverty reduction strategies","volume":"60","author":"Awan","year":"2012","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0103","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2471\/BLT.08.055673","article-title":"Potential lost productivity resulting from the global burden of uncorrected refractive error","volume":"87","author":"Smith","year":"2009","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0104","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/09286580802227394","article-title":"Personal costs of visual impairment by different eye diseases and severity of visual loss","volume":"15","author":"Wong","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/09286580600966623","article-title":"Methods for measuring personal costs associated with vision impairment","volume":"13","author":"Chou","year":"2006","journal-title":"Ophthalmic Epidemiol"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0106","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1167\/iovs.17-23224","article-title":"The economic burden of visual impairment and comorbid fatigue: a cost-of-illness study (from a societal perspective)","volume":"59","author":"Schakel","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101354_bib0107","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030561","article-title":"Burden of visual impairment associated with eye diseases: exploratory survey of 298 Chinese patients","volume":"9","author":"Guan","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0108","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0277-9536(00)00448-2","article-title":"Cataract surgery in a community hospital outreach clinic: patients' costs and satisfaction","volume":"53","author":"Haynes","year":"2001","journal-title":"Soc Sci Med"},{"issue":"7","key":"10.1016\/j.eclinm.2022.101354_bib0109","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bjo.85.7.822","article-title":"Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial","volume":"85","author":"Minassian","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jfo.2010.10.014","article-title":"[Cost of cataract surgery in a public hospital]","volume":"34","author":"Malot","year":"2011","journal-title":"J Fr Ophtalmol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101354_bib0111","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1600-0420.2000.078003335.x","article-title":"Cataract surgery and effectiveness. 1. Variation in costs between different providers of cataract surgery","volume":"78","author":"Lundstrom","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"issue":"1 Suppl","key":"10.1016\/j.eclinm.2022.101354_bib0112","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1002\/hec.1324","article-title":"Cost and reimbursement of cataract surgery in Europe: a cross-country comparison","volume":"17","author":"Fattore","year":"2008","journal-title":"Health Econ"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0113","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.ophtha.2013.04.030","article-title":"Cataract surgery cost utility revisited in 2012: a new economic paradigm","volume":"120","author":"Brown","year":"2013","journal-title":"Ophthalmology"},{"issue":"4 Suppl","key":"10.1016\/j.eclinm.2022.101354_bib0114","first-page":"S90","article-title":"The cost of treating the 10 most prevalent diseases in men 50 years of age or older","volume":"12","author":"Fenter","year":"2006","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ophtha.2014.08.037","article-title":"Cost of intraocular lens versus contact lens treatment after unilateral congenital cataract surgery in the infant aphakia treatment study at age 5 years","volume":"122","author":"Kruger","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0116","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.iae.0000249577.92800.c0","article-title":"Evaluation of costs for cystoid macular edema among patients after cataract surgery","volume":"27","author":"Schmier","year":"2007","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0117","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3129\/i10-094","article-title":"Immediately sequential bilateral cataract surgery versus delayed sequential bilateral cataract surgery: potential hospital cost savings","volume":"45","author":"O'Brien","year":"2010","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0118","first-page":"182","article-title":"Cost of pediatric cataract surgery in Maharashtra, India","volume":"3","author":"Gogate","year":"2010","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0119","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:INTE.0000031738.65787.e9","article-title":"Cost efficiency and cost effectiveness of cataract surgery at the Malaysian Ministry of Health ophthalmic services","volume":"25","author":"Loo","year":"2004","journal-title":"Int Ophthalmol"},{"issue":"100968562","key":"10.1016\/j.eclinm.2022.101354_bib0120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/1471-2458-10-543","article-title":"Variation of cataract surgery costs in four different graded providers of China","volume":"10","author":"Fang","year":"2010","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101354_bib0121","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3928\/01913913-20110726-01","article-title":"Simultaneous bilateral cataract surgery with IOL implantation in children in Kenya","volume":"49","author":"Gradin","year":"2012","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0122","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1590\/S0102-311X2004000100048","article-title":"[Waste of medical tests in preoperative evaluation for cataract surgery]","volume":"20","author":"Arieta","year":"2004","journal-title":"Cad Saude Publica"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101354_bib0123","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1590\/S1807-59322010000400002","article-title":"Phacoemulsification versus extracapsular extraction: governmental costs","volume":"65","author":"Kara","year":"2010","journal-title":"Clinics"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0124","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S0004-27492005000100010","article-title":"[Cost of phacoemulsification in the national campaign of elective cataract surgery in Itapolis, SP, Brazil]","volume":"68","author":"Saad Filho","year":"2005","journal-title":"Arq Bras Oftalmol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.oftal.2016.01.013","article-title":"en representacion del grupo del estudio M. Cost of myopic patients with and without myopic choroidal neovascularisation","volume":"91","author":"Ruiz-Moreno","year":"2016","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"101468102","key":"10.1016\/j.eclinm.2022.101354_bib0126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aos.12141","article-title":"Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?","volume":"91","author":"Hagman","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0127","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ijg.0000212250.95078.6f","article-title":"Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study","volume":"15","author":"Gieser","year":"2006","journal-title":"J Glaucoma"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101354_bib0128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/00325481.2014.994468","article-title":"United States comparative costs and absenteeism of diabetic ophthalmic conditions","volume":"127","author":"Brook","year":"2015","journal-title":"Postgrad Med"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1590\/S0004-27492011000600003","article-title":"Resources use, costs and effectiveness of non-penetrating deep sclerectomy according to glaucoma stage","volume":"74","author":"Guedes","year":"2011","journal-title":"Arq Bras Oftalmol"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189035","article-title":"The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting","volume":"12","author":"Hanemoto","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0131","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.ophtha.2016.01.042","article-title":"Treatment patterns and health care costs for age-related macular degeneration in Japan: an analysis of national insurance claims data","volume":"123","author":"Kume","year":"2016","journal-title":"Ophthalmology"},{"issue":"101321512","key":"10.1016\/j.eclinm.2022.101354_bib0132","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2147\/OPTH.S185052","article-title":"The burden of neovascular age-related macular degeneration: a patient's perspective","volume":"12","author":"Spooner","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101354_bib0133","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00002512-200825030-00007","article-title":"Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy","volume":"25","author":"Bandello","year":"2008","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101354_bib0134","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00019053-200321030-00003","article-title":"The burden of age-related macular degeneration: results of a cohort study in two French referral centres","volume":"21","author":"Bonastre","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13561-016-0116-4","article-title":"Financial burden and quality of life of informal caregivers of patients with wet age-related macular degeneration","volume":"6","author":"Weyer-Wendl","year":"2016","journal-title":"Health Econ Rev"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0136","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clinthera.2012.01.005","article-title":"Cost-effectiveness analysis of ranibizumab versus verteporfin photodynamic therapy, pegaptanib sodium, and best supportive care for the treatment of age-related macular degeneration in Greece","volume":"34","author":"Athanasakis","year":"2012","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0137","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10198-009-0207-9","article-title":"The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration","volume":"11","author":"Ke","year":"2010","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0138","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10198-003-0198-x","article-title":"Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments. A multicenter, prospective 1-year study","volume":"5","author":"Garattini","year":"2004","journal-title":"Eur J Health Econ"},{"issue":"12","key":"10.1016\/j.eclinm.2022.101354_bib0139","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.ophtha.2009.10.023","article-title":"Verteporfin photodynamic therapy cohort study: report 3: cost effectiveness and lessons for future evaluations","volume":"116","author":"Grieve","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101354_bib0140","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3129\/i07-153","article-title":"Burden of illness of neovascular age-related macular degeneration in Canada","volume":"42","author":"Cruess","year":"2007","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101354_bib0141","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/IAE.0b013e3181babd8e","article-title":"A cost-effectiveness analysis of three treatments for age-related macular degeneration","volume":"30","author":"Gower","year":"2010","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0142","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000350802","article-title":"Cost and effectiveness of therapy for wet age-related macular degeneration in routine clinical practice","volume":"230","author":"Studnicka","year":"2013","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101354_bib0143","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4274\/tjo.44370","article-title":"Direct treatment costs of neovascular age-related macular degeneration and comparison of gained and\/or preserved vision with expenditure","volume":"48","author":"Yildirim","year":"2018","journal-title":"Turk J Ophthalmol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:10:18Z","timestamp":1762888218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537022000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":143,"alternative-id":["S2589537022000840"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101354","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The economics of vision impairment and its leading causes: A systematic review","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101354"}}